BBPvsMEDXETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) and Horizon Kinetics Medical ETF (MEDX) belong to the same industry segment: Tomorrow's Treatments. Both ETFs have the same top 3 sector exposures: and Healthcare. BBP is less expensive with a Total Expense Ratio (TER) of 0.34%, versus 0.85% for MEDX. BBP is up 21.54% year-to-date (YTD) with +$40M in YTD flows. MEDX performs worse with 6.9% YTD performance, and -$3M in YTD flows. Run a side-by-side ETF comparison of BBP and MEDX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs MEDX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP MEDX | +0.94%-4.21% | +15.67%+11.46% | +21.54%+6.90% | +56.59%+29.42% | +81.31%+28.36% | +94.15%n/a |
| Flows | BBP MEDX | +$10M-$883K | +$28M-$2M | +$40M-$3M | +$52M-$3M | +$55M-$4M | +$48M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP MEDX | +26.32%+20.91% | +24.02%+18.55% | +24.33%+17.31% | +26.47%n/a |
| Max drawdown | BBP MEDX | -7.49%-7.93% | -9.59%-10.65% | -25.54%-23.05% | -37.61%n/a |
| Max drawdown duration | BBP MEDX | 44d20d | 48d115d | 292d393d | 586dn/a |
Trading data
BBP | MEDX | |
Last sale 7/28/2026 at 1:30 PM | $97.69 | $36.03 |
| Previous close 07/27/2026 | $97.26 | $35.58 |
| Consolidated volume 07/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
MEDX
is actively managed and doesn’t replicate an indexBBP | MEDX | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/28/2026 at 1:30 PM
Live
Closed
BBP | MEDX | |
|---|---|---|
| Last price | $97.69 | $36.03 |
| 1D performance | +0.45% | +1.26% |
| AuM | $96.94 M | $17.59 M |
| E/R | 0.34% | 0.85% |
Characteristics
BBP | MEDX | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VIRTUS Investment Partners | Horizon Kinetics LLC |
| Benchmark | LifeSci Biotechnology Products Index | - |
| N° of holdings | 66 | 30 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | January 27, 2023 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
89.11%
Other
10.89%
MEDX
USA
68.17%
Switzerland
10.22%
United Kingdom
8.49%
Other
13.12%
Sectors
BBP
Healthcare
89.47%
Other
10.53%
MEDX
Healthcare
92.67%
Other
7.33%
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
87.15%
MEDX
Total weight of top 15 holdings out of 15
81.88%
Top 15 holdings
Data as of June 30, 2026
BBP
Verastem, Inc.
44.58%
Legend Biotech Corp.
41.98%
Agios Pharmaceuticals, Inc.
0.05%
BioCryst Pharmaceuticals, Inc.
0.05%
BioMarin Pharmaceutical, Inc.
0.05%
Rigel Pharmaceuticals, Inc.
0.05%
Crinetics Pharmaceuticals, Inc.
0.05%
Madrigal Pharmaceuticals, Inc.
0.05%
BioNTech SE
0.05%
Iovance Biotherapeutics, Inc.
0.05%
Rhythm Pharmaceuticals, Inc.
0.05%
Alnylam Pharmaceuticals, Inc.
0.05%
Incyte Corp.
0.05%
Sarepta Therapeutics, Inc.
0.05%
Omeros Corp.
0.05%
MEDX
Eli Lilly & Co.
18.51%
AbbVie, Inc.
8.87%
Novartis AG
6.80%
Alkermes Plc
5.79%
Johnson & Johnson
5.58%
AstraZeneca PLC
4.93%
Ionis Pharmaceuticals, Inc.
4.62%
Bristol Myers Squibb Co.
4.40%
Merck & Co., Inc.
3.94%
Amgen, Inc.
3.86%
Alnylam Pharmaceuticals, Inc.
3.30%
Biogen, Inc.
3.07%
Pfizer Inc.
2.87%
GSK Plc
2.70%
CRISPR Therapeutics AG
2.64%
Frequently asked questions about BBP and MEDX
How have the BBP and MEDX ETFs performed in 2026?
As of July 27, 2026, BBP is up 21.54% year-to-date (YTD), while MEDX has returned 6.9%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or MEDX?
Year-to-date, the BBP ETF saw +$40M in flows, compared to -$3M for MEDX.
Which ETF is more volatile: BBP or MEDX?
Over the past year, BBP had a volatility of 24.02%, while MEDX experienced 18.55%.
Which ETF is bigger: BBP or MEDX?
As of July 27, 2026, BBP holds $96.94 M in assets under management (AUM), while MEDX manages $17.59 M.
What sectors do the BBP and MEDX ETFs invest in?
BBP leans toward sectors like Healthcare. Meanwhile, MEDX focuses on Healthcare.
What are the top holdings of the BBP ETF and MEDX ETF?
BBP top holdings include Verastem, Inc., Legend Biotech Corp. and Agios Pharmaceuticals, Inc.. MEDX holds in its top three: Eli Lilly & Co., AbbVie, Inc. and Novartis AG.
Which ETF is more diversified: BBP or MEDX?
BBP holds 66 securities with 87.15% of its assets in the top 15. MEDX has 30 securities and a top 15 weight of 81.88%.
Advertisement
Advertisement
